Research peptides in France, Spain and Italy – legal differences

Author: PrimePeptides Research Team.

The legal treatment of research peptides varies between EU member states. An overview of France, Spain and Italy.

France

Research peptides in France fall under ANSM oversight. Importers must ensure products are not classified as medicines. Clear RUO documentation is essential.

Spain

Spain largely follows EU framework regulations. Research customers should ensure complete batch documentation.

Italy

Italian authorities regularly verify intended use. RUO-labeled products are generally unproblematic as long as no medical claims are made.